Aïda Falgàs retweeted
FUNDACIÓN LAIR – Profesor Durantez Award for Best Scientific Article 2025 for “Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo” goes to Laura Díez Alonso, PhD and Aïda Falgàs Comamala 🏆✨congrats !!!!!
Aïda Falgàs retweeted
So proud of Aida Falgàs @aidafc8 from @CarrerasIJC and Javi Arroyo @jarroyo8 from @CNIOStopCancer for being awarded tha best paper from the @jitcancer @sitcancer on next generation CART!
Aïda Falgàs retweeted
We thank @ACIR_org for highlighting our paper, 'CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukaemia progression' published in @jitcancer, co-authored by @jarroyo8 @H12Octubre @CNIOStopCancer & @aidafc8 @CarrerasIJC
To minimize tumor antigen loss and reduce the risk of CD19+ leukemia progression in r/r B-ALL, Arroyo-Ródenas and Falgas et al. developed dual-targeted CD22 CAR T cells secreting an anti-CD19 T cell-engaging antibody (CAR-STAb-T). bit.ly/4mhBc4K @Alvarez_Vallina
Aïda Falgàs retweeted
Happy to share our latest work @Menendez_Lab @clarabueno_74 @aidafc8 @CarrerasIJC in collaboration with the @Alvarez_Vallina Lab at @CNIOStopCancer and @H12Octubre on new CD22 and CD19 T cell redirecting strategies spanning CAR &T-cell engagers (STabs).
pubmed.ncbi.nlm.nih.gov/4030…
Aïda Falgàs retweeted
A privilege to be part of this study published in @BloodJournal and led by @aidafc8 @clarabueno_74 @Menendez_Lab @CarrerasIJC to develop a CAR-T strategy that tricks B-ALL with molecular decoys. Thanks to RLázaro-Gorines and cancer immunotherapy team @CNIOStopCancer @H12Octubre
Aïda Falgàs retweeted
Great collaboration with the Cancer Immunotherapy group lead by Dr Alvarez Vallina @CNIOStopCancer @H12Octubre as well as @LabOrfao @hospitalclinic and many others. Great leadership by @aidafc8 @clarabueno_74!!! Thanks all for making it possible
❕🔬 A new CAR-T-cell therapy that tricks the tumour could increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia #ALL
👉 carrerasresearch.org/en/news…
📋 Results published in @BloodJournal by researchers from @Menendez_Lab and @H12Octubre - @CNIOStopCancer
Thrilled to share our paper published in Blood Journal! @CarrerasIJC @CNIOStopCancer @hospitalclinic @H12Octubre
Huge thanks to everyone involved in this work!
Check out the full paper! lnkd.in/dE_82UpY
#Immunotherapy #CAR19 #BALL
Aïda Falgàs retweeted
🎄🎅🏼 HOHOHO 🎅🏼🎄
Today the Menendez lab celebrating Christmas lunch 🎉
Do you already know who your Secret Santa is? 🤭
🎄🎅🏼HOHOHO 🎅🏼🎄
Merry Christmas to all!
Aïda Falgàs retweeted
Funny days at the #TERAV 2024 annual meeting. Lots of interesting science & a great opportunity for networking @red_terav
Aïda Falgàs retweeted
🏃🏻♀️ Aún estáis a tiempo de apuntaros a la carrera solidaria 𝗢𝗿𝗶𝗲𝗻𝘁𝗮𝗱𝗼𝘀 𝗵𝗮𝘀𝘁𝗮 𝗹𝗮 𝗺𝗲́𝗱𝘂𝗹𝗮 de @HeroesMedula que se celebra el próximo 12 de mayo.
Inscripciones y toda la info aquí 👇🏼oveleta.com/omedula/omedula-…
Juntos somos imparables 💪🏼 🧡
The pleasure has been mine for having had the opportunity to learn from all of you! 🔬🧬
It has been a real pleasure to host @aidafc8 in our laboratory at @CNIOStopCancer @hospital12Oct for 3 months. Excellent work, as part of our strategic collaboration with @CarrerasIJC , @Menendez_Lab @clarabueno_74
Aïda Falgàs retweeted
Proud to share our latest work in STM. The best anti-BCMA killers for Multiple Myeloma. Local leadership in @Menendez_Lab - @clarabueno_74 & @aidafc8. The guiding force & "the boss": @Alvarez_Vallina and team @Hospital12deOct.Thanks 4 the opportunity Luis!
science.org/doi/10.1126/scit…
Aïda Falgàs retweeted
🚨STAb-T cells perform better than CAR-T cells against Multiple Myeloma in preclinical models, a recent study at @ScienceTM found.
Great joint effort by @Alvarez_Vallina @Menendez_Lab @CNIOStopCancer @clarabueno_74 @aidafc8
Read the full story 👇
carrerasresearch.org/en/news…
Aïda Falgàs retweeted
🎙 Exciting research by @aidafc8, @CarrerasIJC, on improving CD19 targeted CAR-T - cell therapy for B-acute lymphoblastic leukemia patients. Blocking the Galectin9-Tim3 pathway shows promising results for increased CAR T-cell persistence and cytotoxicity. #VHIOBBVASymposium
Aïda Falgàs retweeted
First day of #VHIOBBVASymposium cell-based therapies in oncology. Proud of @aidafc8 for her hard work and presentation today! 🚀
Aïda Falgàs retweeted
Reunión anual #TERAV2023 en Alicante. Gracias a @red_terav @saludISCIII por esta iniciativa y por darnos la oportunidad de poder aportar nuestro granito de arena en la investigación nacional de terapias avanzadas. Es un placer seguir aprendiendo todos juntos! Seguimos trabajando!
Aïda Falgàs retweeted
Máxima asistencia a nuestra Reunion Anual 2023. Cada año nos superamos #Ricors/Terav @SaludISCIII @red_terav
I am glad to present our last results at #KindPhillipp2023
#KindPhilipp2023
After a long disco night, Aïda Falgàs rocks in today’s session talking about CARs+immunocheckpoints !!!
































